| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A exon polymorphism rs700519 (R264C) at CYP19 gene locus is associated with the efficacy of adjuvant letrozole in Indian breast carcinoma patients
|
Umamaheswaran, G.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 2 |
Agreement in risk assessment among breast cancer specialists: A survey within the MINDACT cohort
|
Drukker, C.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 3 |
A novel potential prognostic marker SIRT1 on tumor invasion and metastasis, and tumor recurrence in triple negative breast cancer
|
Ryu, H.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 4 |
AP-2gamma as a novel biomarker of endocrine resistance: Results from the TransCONFIRM study
|
Malorni, L.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 5 |
A phase III randomized study of paclitaxel and trastuzumab versus paclitaxel alone for early stage, ER and PR receptor negative and HER2-positive breast cancer as adjuvant treatment
|
Singhal, M.K.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 6 |
A siRNA screen to re-activate senescence in basal-like breast cancer
|
Moore, M.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 7 |
Brain Metastases in Breast Cancer Network Germany (BMBC, GBG 79): Multicentric, retrospective and prospective collection of patient data and biomaterial from breast cancer patients as platform for translational research
|
Müller, V.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 8 |
Breast cancer awareness and early detection practices among Omani women: A cross-sectional survey
|
Al-Khasawneh, E.M.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 9 |
Breast International Group (BIG)
|
|
|
|
26 |
S3 |
p. vi
|
artikel
|
| 10 |
C8A, a potential predictive marker of trastuzmab benefit, is associated with immunological signatures in MSigDB
|
Willis, S.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 11 |
Can pathological complete response serve as a surrogate endpoint for survival?
|
Hariharan, N.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 12 |
CD146/Akt/NF-kappa-B/Latexin, a novel pathway suppressing breast tumor growth
|
Gupta, I.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 13 |
Chemokine expression drives immune cell infiltration in response to oestrogen-deprivation in a model of oestrogen receptor positive breast cancer
|
Dunbier, A.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 14 |
Clinical patterns of metastatic spread from formalin-fixed, paraffin-embedded (FFPE) expression profiles: A case-control study of 1,357 breast cancer patients
|
Lawler, K.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 15 |
Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells
|
Tancredi, R.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 16 |
Comparison of bevacizumab + chemotherapy regimens for triple-negative type locally advanced breast cancer
|
Kenjaeva, A.O.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 17 |
Concordance of local and central HER2 status in 1597 patients participating in German neoadjuvant breast cancer studies
|
Pfitzner, B.M.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 18 |
Consensus on breast cancer cell lines classification for an effective and efficient clinical decision-making
|
Milioli, H.H.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 19 |
Constitutively activated STAT3 is predictive for trastuzumab resistance in primary HER2 positive breast cancer
|
Sonnenblick, A.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 20 |
Contemporary risk of local, regional and contralateral breast cancer recurrence
|
Aalders, K.C.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 21 |
Cost-effectiveness analysis of VEGF-A testing to predict response to bevacizumab (BEV) as a component of neo-adjuvant therapy of early HER-2 negative breast cancer
|
Blank, P.R.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 22 |
CXCL13 and tertiary lymphoid structures formation in the anti-breast cancer immune response
|
Migliori, E.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 23 |
Defining prognostic and therapeutic selective classes of TNBC
|
Knudsen, E.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 24 |
Detection of HER2-status and genomic analysis of disseminated cancer cells (DCCs) of non-metastatic breast cancer patients with HER2-negative and positive primary tumors
|
Doblinger, E.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 25 |
Development and validation of multiplex digital PCR assays on circulating tumor DNA in advanced breast cancer: Implementation for clinical routine use
|
Garcia-Murillas, I.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 26 |
Diagnostic and prognostic role of stromal CD 10 and Ki 67 in benign and malignant phylloides tumor of breast: A pilot study
|
Kumar, S.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 27 |
Differential expression of the protein phosphatase 2 (PP2A) complex and breast cancer signature genes following suppression of mTOR signalling
|
Saliba, C.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 28 |
Differential microRNA expression in breast cancer patients aged 35 years or younger
|
Ribas, G.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 29 |
Discordance with estrogen receptor alpha status estimated by immunohistochemical and immunofluorescent method associated with flowcytometry in breast cancer tissue
|
Rodionova, M.V.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 30 |
3D MRI for quantitative analysis of quadrant percent breast density (QPD): Correlation with quadrant location of breast cancer
|
Chen, J.-H.
|
|
|
26 |
S3 |
p. iii27
|
artikel
|
| 31 |
drug index
|
|
|
|
26 |
S3 |
p. iii34
|
artikel
|
| 32 |
Dual role of endothelial cell signaling in cancer progression
|
Ferraro, D.A.
|
|
|
26 |
S3 |
p. iii29
|
artikel
|
| 33 |
EBC Council
|
|
|
|
26 |
S3 |
p. viii
|
artikel
|
| 34 |
Editorial Board
|
|
|
|
26 |
S3 |
p. ii-iii
|
artikel
|
| 35 |
Effect of delays in time to fixation due to routine X-ray of surgical breast cancer specimens on gene expression profiles
|
Lopez Knowles, E.C.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 36 |
Effect of long term yoga practice on psychological and immune outcomes in breast cancer survivors
|
Ram, A.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 37 |
Estimated number of Korean women who could benefit from tamoxifen or raloxifene for breast cancer chemoprevention: data from the Korea National Health and Nutrition Examination Survey
|
Chang, M.-C.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 38 |
Evaluation of PDL1 expression in breast cancer by immunohistochemistry
|
Solinas, C.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 39 |
Evaluation of the role of MCPH1 and p53 expression in response to chemotherapy and subsequent survival in breast cancer
|
Awaji, A.A.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 40 |
Examination of the sentinel lymph node identification in breast cancer combining contrast-enhanced ultrasonography and the blue dye method without radioisotope
|
Futsuhara, K.
|
|
|
26 |
S3 |
p. iii27
|
artikel
|
| 41 |
Exploring the intra-patient PIK3CA mutational heterogeneity of circulating tumour cells by massive parallel sequencing in patients with metastatic hormone receptor-positive breast cancer
|
De Laere, B.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 42 |
Expression of CD138 / syndecan-1 in triple-negative breast cancer – correlative study of GeparSixto
|
von Minckwitz, G.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 43 |
Expression of cohesin subunit SA2 predicts breast cancer survival
|
Repo, H.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 44 |
Expression of the small GTPase Rab27B is associated with stromal inflammation in ductal carcinoma in situ of the breast
|
Van Bockstal, M.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 45 |
Expression of transcription factor FOXP1 in the immune response to breast cancer
|
De Silva, P.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 46 |
Foundation “St.Gallen Oncology Conferences” (SONK)
|
|
|
|
26 |
S3 |
p. ix
|
artikel
|
| 47 |
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
|
Aaltonen, K.E.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 48 |
Genetic study of triple negative breast cancers
|
Boukerroucha, M.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 49 |
Germ cells and mammary gland transcritome comparison generate a powerful gene expression profile that predicts breast cancer survival
|
Tiezzi, D.G.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 50 |
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis
|
Kammerer, S.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 51 |
Heterogeneous responses of triple negative breast cancer cell lines to radiation and pharmacological treatments
|
Xie, X.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 52 |
High reduction of circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin)
|
Manso, L.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 53 |
Histology and molecular characteristics of pregnancy associated breast cancer
|
Tomasevic, Z.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 54 |
Identification of gene expression signatures of palbociclib (PD) response in breast cancer (BC)
|
Migliaccio, I.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 55 |
IMPAKT 2015 Officers
|
|
|
|
26 |
S3 |
p. x
|
artikel
|
| 56 |
Incidence of oncogenes in PI3K/AKT and MAPK signaling pathways in breast cancer
|
Cejalvo, J.M.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 57 |
Influence of anthracycline- and/or taxane-based chemotherapy on bone metabolism of patients with primary breast cancer
|
Kurbacher, C.M.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 58 |
Infrared imaging: A potential new tool to probe tumor cells and their immune micro-environment in breast cancer?
|
Verdonck, M.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 59 |
Inhibition of triple negative and herceptin-resistant breast cancer proliferation and migration by annexin A2 antibodies
|
Vishwanatha, J.K.
|
|
|
26 |
S3 |
p. iii29
|
artikel
|
| 60 |
Interleukin-6 expression is involved in the response to HER2-targeted therapy in breast cancer
|
Chen, Y.-J.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 61 |
Intravenous thiotepa for treatment of leptomeningeal carcinomatosis: Retrospective case series
|
Chahal, J.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 62 |
KEYNOTE-012: A phase Ib study of pembrolizumab (MK-3475) in patients (pts) with metastatic triple-negative breast cancer (mTNBC)
|
Buisseret, L.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 63 |
Lipid profiles of young Chinese breast cancer after adjuvant chemotherapy
|
Yeo, W.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 64 |
Location of triple-negative breast cancers: Comparison with estrogen receptor-positive breast cancers on MR imaging
|
Moon, W.K.
|
|
|
26 |
S3 |
p. iii27
|
artikel
|
| 65 |
Low hormone receptor (HR) status and the benefit of hormonal therapy (HT) in patients with early breast cancer (EBC)
|
Guarducci, C.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 66 |
Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer
|
Schwarzenbacher, D.
|
|
|
26 |
S3 |
p. iii29
|
artikel
|
| 67 |
Male breast cancer receptor sub-types: Demographics, tumor characteristics and short term survival outcomes
|
Yadav, S.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 68 |
MiR-16 is the most stable-expressed housekeeping microRNA in breast cancer tissues from primary and metastatic sites
|
Rinnerthaler, G.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 69 |
Molecular characterization of breast cancer brain metastases and circulating tumor cells
|
Wikman, H.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 70 |
Molecular classification of basal-like breast cancer subtypes based on predictive survival markers
|
Milioli, H.H.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 71 |
Molecular cochaperone & its deregulation in breast cancer
|
Tan, K.-L.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 72 |
Multigene sequencing for the genetic diagnostics of patients with early-onset or familial breast cancer
|
Lin, P.-H.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 73 |
Nectin4 effects in the tumor phenotype
|
Ghidouche, A.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 74 |
Neoadjuvant chemotherapy in breast cancer patients induces miR-34a expression
|
Freres, P.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 75 |
Outcome analysis of patients with breast cancer and positive sentinel node
|
Syed, A.
|
|
|
26 |
S3 |
p. iii4
|
artikel
|
| 76 |
P14ARF-p53-p21 alters the metabolic pathway in breast cancer – a novel proteomic global approach
|
Hatoum, D.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 77 |
Pathological complete response (pCR) is not a good marker for inflammatory breast cancer (IBC) patients to predict improved long-term survival after neoadjuvant chemotherapy (NT)
|
Fei, F.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 78 |
Phosphoproteomic assessment of HER2 signaling pathway in HER2 non-amplified patients of the GeparQuattro and GeparQuinto trials
|
Avril, S.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 79 |
PI3 kinase/mTOR inhibition increases sensitivity of ER positive breast cancers to CDK4/6 inhibition by blocking cell cycle re-entry driven by cyclinD1 and inducing apoptosis
|
Herrera-Abreu, M.T.
|
|
|
26 |
S3 |
p. iii29
|
artikel
|
| 80 |
p53 mutations in HER2 positive and triple negative breast cancer treated with neoadjuvant chemotherapy – A translational subproject of the GeparSixto trial
|
Darb-Esfahani, S.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 81 |
Pregnancy-associated breast cancer: Influence of gestation length and breastfeeding on survival in a population based cohort
|
Mackie, J.
|
|
|
26 |
S3 |
p. iii1
|
artikel
|
| 82 |
Profiles of genome complexity identify HORMAD1 as a driver of homologous recombination deficiency and platinum therapy response in triple-negative breast cancer
|
Grigoriadis, A.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 83 |
Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes
|
Nuzzo, P.V.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 84 |
Radiotherapy plus trastuzumab in the treatment of Her2-positive locally advanced breast cancer
|
Belokhvostova, A.
|
|
|
26 |
S3 |
p. iii4
|
artikel
|
| 85 |
Relevance of &bgr;ß-Gal-ß-GalNAc-containing O-glycans and the enzymes involved in their synthesis for vascular and lymphatic invasion and survival in breast cancer patients
|
Milde-Langosch, K.
|
|
|
26 |
S3 |
p. iii29
|
artikel
|
| 86 |
Relevance of glycosylation-associated genes for tumor progression and metastasis localization in breast cancer
|
Oliveira-Ferrer, L.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 87 |
Repeatability evaluation of PET/CT imaging using [18F]fluorothymidine (FLT) and [18F]fluorodeoxyglucose (FDG) in primary triple negative breast cancer (TNBC)
|
Glendenning, J.L.
|
|
|
26 |
S3 |
p. iii27
|
artikel
|
| 88 |
Retinoic acid signaling in human breast cancer cells: A phosphoproteomic approach
|
Carrier, M.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 89 |
Smart delivery of lapatinib to reduce its cardiotoxicity: A 99mTc labeled biodistribution study
|
Khanna, A.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 90 |
Soluble serum Fas as a biomarker of early detection of bone or liver metastases in women with advanced breast cancer. A preliminary case-control study
|
Lumachi, F.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 91 |
Somatic BRCA1 mutations determine different responses to platinum-based chemotherapy
|
Ignatova, E.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 92 |
Stage 1 results from MDV3100-11: A 2-stage study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)
|
Cortes Castan, J.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 93 |
Standardize uptake value of 18F-FDG-PET-CT is in accordance with the 21-gene recurrence score (Oncotype Dx) in ER-positive and HER2-negative breast cancer patients
|
Ahn, S.G.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 94 |
Stromal protein expression in breast cancer is differentially regulated by TGF-&bgr;1
|
Van Bockstal, M.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 95 |
Table of Contents
|
|
|
|
26 |
S3 |
p. v
|
artikel
|
| 96 |
Targeting HER2 in patients with HER2-negative metastatic breast cancer with elevated serum levels of the HER2 extracellular domain and/or HER2-positive circulating tumor cells in the clinical routine
|
Kurbacher, C.M.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 97 |
Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer
|
van Geldermalsen, M.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 98 |
Targeting the hedgehog signalling pathway in triple negative breast cancer
|
Hui, M.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 99 |
Targeting unique metabolic vulnerabilities in dormant ER+ tumor cells
|
Knudsen, E.
|
|
|
26 |
S3 |
p. iii29
|
artikel
|
| 100 |
The Breast International Group (BIG) AURORA pilot study for molecular screening in metastatic breast cancer (MBC) patients
|
Maetens, M.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 101 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
26 |
S3 |
p. vii
|
artikel
|
| 102 |
The GATA3 and SENP5 network demonstrates control over breast cancer phenotypes
|
Efroni, S.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 103 |
The impact of the uPAR system and its interaction partners as potential therapeutic targets in TNBC
|
Huber, M.
|
|
|
26 |
S3 |
p. iii15
|
artikel
|
| 104 |
The tyrosine kinase AXL sustains EMT and tumour-associated inflammation in triple-negative breast cancers
|
Raschioni, C.
|
|
|
26 |
S3 |
p. iii31
|
artikel
|
| 105 |
Title Page
|
|
|
|
26 |
S3 |
p. iv
|
artikel
|
| 106 |
Transarterial chemoembolization with doxorubicin-loaded drug-eluting beads (DEBDOX) in the treatment of breast cancer liver metastases: A pilot study
|
Bruixola, G.
|
|
|
26 |
S3 |
p. iii6
|
artikel
|
| 107 |
translational research index
|
|
|
|
26 |
S3 |
p. iii35
|
artikel
|
| 108 |
Tumour infiltrating lymphocytes in inflammatory breast cancer
|
Colpaert, C.G.
|
|
|
26 |
S3 |
p. iii25
|
artikel
|
| 109 |
Whole exome sequencing of circulating and disseminated tumour cells in patients with metastatic breast cancer
|
Peeters, D.
|
|
|
26 |
S3 |
p. iii10
|
artikel
|
| 110 |
10-year results of complex treatment with reactor neutrons in locally advanced breast cancer (BC)
|
Ragulin, Y.
|
|
|
26 |
S3 |
p. iii4
|
artikel
|
| 111 |
ZOO 11 trial: Does it influence our clinical practice in the United Kingdom
|
Syed, A.
|
|
|
26 |
S3 |
p. iii4
|
artikel
|
Tijdschrift beschrijving